Q1 2026 Holdings
Filed 2026-05-15 | 10 holdings | $163.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $47.6M | 2,392,150 | 29.2% |
| Nuvation Bio Inc.(NUVB) | Common Stock Class A | 67080N101 | $34.7M | 8,081,089 | 21.2% |
| BridgeBio Oncology Therapeutics Inc.(BBOT) | Common Stock | 107924102 | $29.4M | 3,289,661 | 18.0% |
| Kestra Med Technologies Ltd(KMTS) | Common Stock | G52441105 | $20.4M | 1,022,149 | 12.5% |
| Beta Bionics Inc.(BBNX) | Common Stock | 08659B102 | $13.2M | 1,316,183 | 8.1% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $6.0M | 876,357 | 3.7% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $5.3M | 241,255 | 3.3% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $2.4M | 843,750 | 1.5% |
| ImageneBio, Inc.(IMA) | Common Stock | 45175G207 | $2.3M | 455,361 | 1.4% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $1.9M | 248,672 | 1.2% |